Skip to main content
. Author manuscript; available in PMC: 2014 Sep 27.
Published in final edited form as: Cochrane Database Syst Rev. 2003 Apr 22;(2):CD002217. doi: 10.1002/14651858.CD002217
Methods A crossover trial with 21 day treatment periods.
Double blind.
Randomization method not stated.
Method of allocation concealment not stated.
Participants Institutionalized adult patients with uncontrolled epilepsy.
91% of participants had partial epilepsy.
Number randomized = PHB group = 45 people, PHT group = 45 people.
62% of participants were male.
Age range 18-51 years.
Interventions Monotherapy with PHB or PHT.
Median daily dose achieved not stated.
Outcomes Seizure frequency.
Time to treatment withdrawal.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear